Virological and Serological Assessment of US Army Trainees Isolated for Coronavirus Disease 2019
Abstract
Laboratory screening for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a key mitigation measure to avoid the spread of infection among recruits starting basic combat training in a congregate setting. Because viral nucleic acid can be detected persistently after recovery, we evaluated other laboratory markers to distinguish recruits who could proceed with training from those who were infected.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- May 11, 2022
- Source ID
- 10.1093/infdis/jiac198
Entities
People
- Aaron D Sanborn
- Brittany L Ober Shepherd
- Clinton K. Murray
- Crystal L Brigantti
- David B. King
- Elizabeth J. Bianchi
- Inès Lakhal-Naouar
- Janice M. Darden
- Jason A. Pieri
- Jason Ouellette
- Jennifer L Burns
- Jeremiah Stubbs
- Kayvon Modjarrad
- Kenya N Jackson
- Linda L. Jagodzinski
- Melanie D Mccauley
- Milford H. Beagle Jr.
- Paul O. Kwon
- Paul T. Scott
- Prabha Chandrasekaran
- Robert J. O'connell
- Samantha Mchenry
- Sharon P. Daye
- Sheila A. Peel
- Shilpa Hakre
- Stephen W. Krauss
- Tara L. Hall
- Timothy R. Frambes
Organizations
- 10th Mountain Division
- Henry M. Jackson Foundation for the Advancement of Military Medicine
- San Antonio Military Medical Center
- United States Army
- United States Army Medical Research and Development Command
- United States Department of Defense
- Walter Reed Army Institute of Research